← Open Payments lookup

AJLA UZICANIN: Open Payments

NPI 1083447031 · WEBSTER, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$4,880 in 138 payments from 18 companies in 2025. Trend: 2023 $0 · 2024 $846 · 2025 $4,880

Food & beverage: $4,762Education: $115Travel & lodging: $3
CompanyPaymentsAmount
Madrigal Pharmaceuticals24$1,429
ABBVIE INC.37$1,296
Janssen Biotech, Inc.15$460
Takeda Pharmaceuticals U.S.A., Inc.14$423
Lilly USA, LLC7$231
Celltrion USA Inc.5$181
Phathom Pharmaceuticals, Inc.5$170
GENZYME CORPORATION3$168
Salix Pharmaceuticals, a division of Bausch Health US, LLC10$148
Biocon Biologics Inc3$65

Products named: REZDIFFRA, SKYRIZI, TREMFYA, RINVOQ, ENTYVIO, OMVOH, VOQUEZNA, DUPIXENT.

Industry payments across TX — which companies pay providers there.